Sarepta Therapeutics Appoints Michael Severino, M.D., Chief Executive Officer
SRPT•CEO appointment and retirement timeline
July 27 (Reuters) - Sarepta Therapeutics Inc SRPT.O:
- Sarepta Therapeutics appoints Michael Severino, M.D., chief executive officer
- Sarepta Therapeutics - Doug Ingram to retire and serve as advisor until end of 2026




